Last reviewed · How we verify
NCT03924063: Hemiverse
Safety of the Hemiverse Shoulder Prothesis
NA trial testing Hemiverse in Rotator Cuff Tear. Withdrawn.
14 May 2021
Quick facts
| Lead sponsor | Balgrist University Hospital |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 14 May 2021 |
| Primary completion | 14 May 2021 |
| Estimated completion | 14 May 2021 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Hemiverse
Conditions studied
- Rotator Cuff Tear — all drugs for Rotator Cuff Tear →
- Hemiarthroplasty — all drugs for Hemiarthroplasty →
Sponsor
Balgrist University Hospital
Who can join
65 and older, any sex, with Rotator Cuff Tear or Hemiarthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial investigates the safety and the preliminary clinical benefit of the hemiverse shoulder prosthesis. Implantation of this newly developed hemi-prosthesis is intended for patients who do not qualify for a regular reverse or hemi-prosthesis due to severe medical conditions, poor bone stock or critical status of the rotator cuff. The expected benefit is, that patients will have a minimally invasive surgical procedure, only addressing the humeral shaft, however with the biomechanical advantage of a total reverse shoulder prosthesis, meaning, that with a minimally invasive surgery a comparable result as with a regular total shoulder prosthesis is accomplished. Patients will be closely monitored within the study protocol for 18 months and thereafter in regular interval was as with a normal prosthetic followup.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03924063
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rotator Cuff Tear
Currently open trials in the same condition.
- NCT07412184 — Research and Clinical Validation of a Wearable Device-Based Remote Rehabilitation System for Postoperative Rotator Cuff · NA · recruiting
- NCT06918041 — FiberLocker® System Augmentation of Rotator Cuff Repairs · NA · recruiting
- NCT07005063 — Rotator Cuff Tendon Repair With FiberLocker System Patch Augmentation · NA · recruiting
- NCT06878391 — ISB With SSNB & ANB · NA · recruiting
- NCT06766630 — Exploring the Feasibility of Silk Fibroin Surgical Mesh in Rotator Cuff Tears Repair Enhancement · Phase 2, PHASE3 · recruiting
Other Balgrist University Hospital trials
Trials by the same sponsor.
- NCT06813859 — Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device · not yet recruiting
- NCT06668116 — The Impact of Local Anesthetic Dilution on Possible Blinding for Nerve Blocks · NA · completed
- NCT06552195 — Augmented Reality in Learning Anatomy: The TEACHANATOMY Randomized Cross-over Trial · NA · not yet recruiting
- NCT06443879 — Loss and Return of Sensation After Axillary Brachial Plexus Nerve Block - Distally or Proximally · completed
- NCT06036849 — Linking Physiological Responses to Clinical Outcomes Following Cervical Spine Manipulation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03924063 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Balgrist University Hospital
- Last refreshed: 15 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03924063.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing